Status:
UNKNOWN
Carotid Artery Plaque Vulnerability Assessment Using Ultrafast Ultrasound Techniques
Lead Sponsor:
Radboud University Medical Center
Collaborating Sponsors:
Rijnstate Hospital
Conditions:
Carotid Artery Plaque
Eligibility:
All Genders
18+ years
Brief Summary
Objective: To explore the association between spatio-temporal blood flow velocities (peak systole and end-diastole at prior-stenosis, at maximum stenosis, and post-stenosis) and carotid plaque vulnera...
Eligibility Criteria
Inclusion
- Presence of carotid artery stenosis (≥50%) according to conventional clinically performed imaging (duplex/CT(A)/MR(A)) and scheduled for a CEA;
- Possibility to perform carotid ultrasound ≤2 weeks before the CEA
- ≥18 years old;
- Able to provide signed or oral informed consent.
Exclusion
- Hampered carotid blood flow imaging during clinically performed duplex/doppler measurements due to near to total carotid occlusion at the side of interest or a calcified plaque;
- Restenosis after carotid revascularisation at side of interest;
- Participating in another clinical study, interfering on outcomes;
Key Trial Info
Start Date :
February 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2023
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT05218421
Start Date
February 1 2022
End Date
November 1 2023
Last Update
February 1 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Rijnstate Hospital
Arnhem, Netherlands
2
Radboud university medical center
Nijmegen, Netherlands